GAMMA Investing’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9M Buy
78,530
+6,508
+9% +$1.52M 0.74% 20
2026
Q1
$17.6M Buy
72,022
+10,268
+17% +$2.39M 0.82% 18
2025
Q4
$12.8M Buy
61,754
+7,245
+13% +$1.43M 0.64% 20
2025
Q3
$10.1M Buy
54,509
+5,142
+10% +$881K 0.56% 26
2025
Q2
$7.54M Buy
49,367
+5,859
+13% +$901K 0.48% 29
2025
Q1
$7.22M Buy
43,508
+14,118
+48% +$2.21M 0.54% 29
2024
Q4
$4.25M Sell
29,390
-6,534
-18% -$1.01M 0.36% 37
2024
Q3
$5.82M Buy
35,924
+10,332
+40% +$1.65M 0.58% 23
2024
Q2
$3.74M Buy
25,592
+5,038
+25% +$749K 0.51% 23
2024
Q1
$3.25M Buy
20,554
+2,931
+17% +$467K 0.66% 20
2023
Q4
$2.8M Buy
+17,623
New +$2.7M 0.76% 18

Other funds holding JNJ

GAMMA Investing's JNJ Position: Q2 2026 in Review

GAMMA Investing increased its Johnson & Johnson (JNJ) stake by 9% in Q2 2026, buying an estimated $1.52M and bringing the position to 78,530 shares worth $19.9M. The position accounts for 0.74% of the portfolio, ranked #20.

GAMMA Investing first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 3,371 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • GAMMA Investing held 78,530 shares of Johnson & Johnson worth $19.9M as of Q2 2026.
  • GAMMA Investing bought 6,508 Johnson & Johnson shares in Q2 2026, an estimated $1.52M.
  • Johnson & Johnson made up 0.74% of GAMMA Investing's portfolio in Q2 2026, its #20 holding.
  • GAMMA Investing first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 3,371 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.